Position in ARVN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,268,625
-$822,953 QoQ
Shares Held
1,356,032
+18.9% QoQ
Ownership
2.07%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#12
of 198 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. ARVN ranks #44 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in ARVN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,268,625 | 1,356,032 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $12,091,578 | 1,140,715 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $12,986,687 | 1,094,999 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $5,801,139 | 680,885 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $5,055,670 | 686,912 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $6,884,330 | 980,674 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $910,401 | 47,491 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,305,592 | 134,210 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,694,490 | 176,352 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $7,098,632 | 171,963 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,681,232 | 138,028 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $2,047,627 | 104,258 | Shares | Defined | 2023-11-13 | |
| 2022-12-31 | $74,919 | 2,190 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $71,984 | 1,618 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $67,975 | 1,615 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $134 | 2 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,149 | 14 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,081 | 74 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,509,352 | 45,576 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,064,224 | 61,486 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $580,751 | 6,838 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $338,779 | 14,349 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $867,377 | 25,861 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $7,622,503 | 189,144 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||